Patents by Inventor Mark A. ILGEN

Mark A. ILGEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230051263
    Abstract: An automated microfluidic bioreactor device and methods to rapidly detect drugs of abuse from human sweat are provided. The bioreactor can perform either single-plexed measurements (detecting only one target analyte at a time) or multiplexed measurement (detecting multiple analytes simultaneously). The bioreactor device has a cartridge comprising a capillary array that employs competitive enzyme-linked immunosorbent assay (ELISA) to detect the presence of various drugs or metabolite compounds. For example, four common drugs, methadone, methamphetamine, amphetamine, and tetrahydrocannabinol, were detected rapidly and quantitatively in about 16 minutes with a low sweat sample volume (about 4 ?L per analyte) and a large dynamic range (methadone: 0.0016 ng/mL-1 ng/mL; METH: 0.016 ng/mL-25 ng/mL; amphetamine: 0.005 ng/mL-10 ng/mL; THC: 0.02 ng/mL-1000 ng/mL).
    Type: Application
    Filed: January 11, 2021
    Publication date: February 16, 2023
    Applicants: THE REGENTS OF THE UNIVERSITY OF MICHIGAN, ARBORSENSE INC., OPTOFLUIDIC BIOASSAY, LLC
    Inventors: Xudong FAN, Wen XUE, Xiaotian TAN, Mark A. ILGEN, Girish KULKARNI, Maung Kyaw KHAING OO